Cann American Corp. (CNNA)
Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
OTC:CNNA
As of the Oct 30, 2026 FINRA settlement, 184,332 CNNA shares were sold short (0.05% of a 377.22M-share float, 1.44 days to cover).